Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis.

@article{Wyatt2008IdentificationOA,
  title={Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis.},
  author={E. Wyatt and W. R. Galloway and Gemma L. Thomas and M. Welch and O. Loiseleur and A. Plowright and D. R. Spring},
  journal={Chemical communications},
  year={2008},
  volume={40},
  pages={
          4962-4
        }
}
The screening of a diversity-oriented synthesis library followed by structure-activity relationship investigations have led to the discovery of an anti-MRSA agent which operates as an inhibitor of Staphylococcus aureus dihydrofolate reductase. 
View on PubMed
rsc.org
40 Citations
Background Citations
6
Methods Citations
1

Figures and Tables from this paper

40 Citations

Citation Type

Citation Type

Inhibitor design to target a unique feature in the folate pocket of Staphylococcus aureus dihydrofolate reductase.
The discovery of antibacterial agents using diversity-oriented synthesis.
  • 89
Diversity-oriented synthesis of bicyclic and tricyclic alkaloids.
  • 34
  • PDF
Three-component assembly of structurally diverse 2-aminopyrimidine-5-carbonitriles.
  • 11
Following the Lead from Nature: Divergent Pathways in Natural Product Synthesis and Diversity-Oriented Synthesis
  • 45
Discovery of new antimalarial chemotypes through chemical methodology and library development
  • 34
  • PDF
Synthesis of 6-arylisocytosines and their potential for hydrogen bonding interactions
  • 5
Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.
  • 363
  • PDF
[Diversity-oriented synthesis and its application in drug discovery].
  • 1
A two-directional strategy for the diversity-oriented synthesis of macrocyclic scaffolds.
  • 24
  • PDF
...
1
2
3
4
...

References

SHOWING 1-10 OF 42 REFERENCES
Gemmacin B: bringing diversity back into focus.
  • 30
  • PDF
Antibacterial discovery and development—the failure of success?
  • 211
Dihydrofolate reductase inhibitors as antibacterial agents.
  • 239
Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
  • 58
Anti-MRSA agent discovery using diversity-oriented synthesis.
  • 100
  • PDF
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.
  • 144
Iclaprim. Antibacterial dihydrofolate reductase inhibitor
  • 14
Inhibition of bovine dihydrofolate reductase and enhancement of methotrexate sensitivity by N4-(2-acetoxyethoxymethyl)-2-acetylpyridine thiosemicarbazone.
  • 9
Skeletal diversity construction via a branching synthetic strategy.
  • 75
  • PDF
Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone.
  • 46
  • PDF
...
1
2
3
4
5
...